C. Tevi-Benissan

发表

Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC Al and A2 category) patients with HIV-1 and HIV-2 infection

L. Bélec, J. Gilquin, C. Tevi-Benissan, 2005, Journal of Clinical Immunology.

Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women.

L. Bélec, J. Malkin, C. Tevi-Benissan, 1995, Cytokine.

Public Health Impact After the Introduction of PsA-TT: The First 4 Years

Ryan T Novak, B. Greenwood, D. Caugant, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protection of cynomolgus macaque against cervicovaginal transmission of SIVmac251 by the spermicide benzalkonium chloride.

M. Georges-Courbot, L. Bélec, A. Georges, 2000 .

In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride.

L. Bélec, J. Malkin, M. Beumont‐Mauviel, 2000, The Journal of antimicrobial chemotherapy.

In vivo semen-associated pH neutralization of cervicovaginal secretions

L. Bélec, G. Grésenguet, C. Tevi-Benissan, 1997, Clinical and diagnostic laboratory immunology.

Global practices of meningococcal vaccine use and impact on invasive disease

Z. Bhutta, D. Durrheim, J. Eskola, 2014, Pathogens and global health.

Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.

L. Bélec, C. Tevi-Benissan, T. Prazuck, 1995, The Journal of infectious diseases.

Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.

L. Bélec, C. Tevi-Benissan, T. Prazuck, 1995, AIDS Research and Human Retroviruses.

Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.

L. Cooper, O. Ronveaux, J. Stuart, 2017, The Lancet. Infectious diseases.

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

Ryan T Novak, S. Hugonnet, D. Caugant, 2012, Vaccine.

The status of hepatitis B control in the African region

R. Tohme, R. Mihigo, C. Tevi-Benissan, 2017, The Pan African medical journal.

Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays

L. Bélec, A. Georges, C. Tevi-Benissan, 1995, Clinical and diagnostic laboratory immunology.

Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries

Minal K. Patel, R. Mihigo, C. Tevi-Benissan, 2018, Journal of immunological sciences.

Countries’ interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions

Anna-Léa Kahn, C. Tevi-Benissan, K. Hennessey, 2017, Vaccine.

Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: Possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim

L. Bélec, C. Tevi-Benissan, J. Pillot, 1995, Journal of medical virology.

HIV-1 antibody serum negativity with vaginal secretions positivity

L. Bélec, G. Grésenguet, C. Tevi-Benissan, 1994, The Lancet.

Human immunodeficiency virus type 1 p24 antigen in cervicovaginal secretions.

L. Bélec, G. Grésenguet, C. Tevi-Benissan, 1995, The Journal of infectious diseases.

Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.

S. R. Zaki, A. Sanchez, M. Georges-Courbot, 1997, Emerging infectious diseases.

A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization

J. Hombach, M. C. Danovaro-Holliday, J. Ortiz, 2016, Vaccine.

Global epidemiology of invasive meningococcal disease

Z. Bhutta, D. Durrheim, J. Eskola, 2013, Population Health Metrics.

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014

Ryan T Novak, W. Perea, F. Diomandé, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Enhanced detection of human herpesvirus-8 and cytomegalovirus in semen of HIV-seropositive asymptomatic heterosexual men living in Central Africa.

L. Bélec, G. Grésenguet, C. Tevi-Benissan, 1998, AIDS.

Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.

E. Mavoungou, C. Tevi-Benissan, V. Poaty‐Mavoungou, 2002, Viral immunology.

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad.

P. Lydon, M. Zaffran, M. Djingarey, 2014, Bulletin of the World Health Organization.

Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022

M. Mikoleit, Yoann Nedelec, A. Tiffany, 2023, MMWR. Morbidity and mortality weekly report.

Cervicovaginal HIV-1 and HIV-2 cross-reactivities.

H. Hocini, L. Bélec, P. Becquart, 1997, International Journal of STD and AIDS.

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region

J. Okeibunor, B. Anya, D. Cheikh, 2017, The Journal of infectious diseases.

Elimination of Epidemic Meningitis in the African Region: Progress and Challenges: 2010-2016

J. Okeibunor, O. Ronveaux, M. Djingarey, 2018, Journal of immunological sciences.